Literature DB >> 11691782

Phenotypic analysis of hMSH2 mutations in mouse cells carrying human chromosomes.

G Marra1, S D'Atri, H Yan, C Perrera, E Cannavo', B Vogelstein, J Jiricny.   

Abstract

Conversion of diploidy to haploidy is a method that allows the generation of stable murine/human hybrid cell lines carrying selected human chromosomes in only a single copy. In this setting, it is possible to detect genetic mutations with greater sensitivity and reliability than in diploid cells. Using this method, we were able to identify mutations in the human mismatch repair (MMR) gene hMSH2 in hereditary nonpolyposis colon cancer families, which have escaped detection by the conventional methods. In this report, we show that such hybrid cell lines can also be a valuable tool in the study of the mutated MMR proteins, in particular the variants found in hereditary nonpolyposis colon cancer families that carry missense mutations and where it is unclear whether they predispose to colon cancer. This analysis is made possible by the fact that the human hMSH2 protein is able to complement the MMR defect in the host murine cell line.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11691782

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.

Authors:  Graham Casey; Noralane M Lindor; Nickolas Papadopoulos; Stephen N Thibodeau; John Moskow; Scott Steelman; Carolyn H Buzin; Steve S Sommer; Christine E Collins; Malinda Butz; Melyssa Aronson; Steven Gallinger; Melissa A Barker; Joanne P Young; Jeremy R Jass; John L Hopper; Anh Diep; Bharati Bapat; Michael Salem; Daniela Seminara; Robert Haile
Journal:  JAMA       Date:  2005-02-16       Impact factor: 56.272

2.  Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.

Authors:  Christiane Rudolph; Cecilie Melau; John E Nielsen; Kristina Vile Jensen; Dekang Liu; Javier Pena-Diaz; Ewa Rajpert-De Meyts; Lene Juel Rasmussen; Anne Jørgensen
Journal:  Cell Oncol (Dordr)       Date:  2017-05-23       Impact factor: 6.730

3.  The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.

Authors:  W D Foulkes; I Thiffault; S B Gruber; M Horwitz; N Hamel; C Lee; J Shia; A Markowitz; A Figer; E Friedman; D Farber; C M T Greenwood; J D Bonner; K Nafa; T Walsh; V Marcus; L Tomsho; J Gebert; F A Macrae; C L Gaff; B Bressac-De Paillerets; P K Gregersen; J N Weitzel; P H Gordon; E MacNamara; M-C King; H Hampel; A De La Chapelle; J Boyd; K Offit; G Rennert; G Chong; N A Ellis
Journal:  Am J Hum Genet       Date:  2002-11-26       Impact factor: 11.025

Review 4.  Genetic factors and colorectal cancer in Ashkenazi Jews.

Authors:  Gershon Y Locker; Henry T Lynch
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 5.  A636P testing in Ashkenazi Jews.

Authors:  Jose G Guillem; Harvey G Moore; Crystal Palmer; Emily Glogowski; Rob Finch; Khedoudja Nafa; Arnold J Markowitz; Kenneth Offit; Nathan A Ellis
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

6.  Assessment of functional effects of unclassified genetic variants.

Authors:  Fergus J Couch; Lene Juel Rasmussen; Robert Hofstra; Alvaro N A Monteiro; Marc S Greenblatt; Niels de Wind
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

7.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4).

Authors:  Ying-Zhang Chen; Craig L Bennett; Huy M Huynh; Ian P Blair; Imke Puls; Joy Irobi; Ines Dierick; Annette Abel; Marina L Kennerson; Bruce A Rabin; Garth A Nicholson; Michaela Auer-Grumbach; Klaus Wagner; Peter De Jonghe; John W Griffin; Kenneth H Fischbeck; Vincent Timmerman; David R Cornblath; Phillip F Chance
Journal:  Am J Hum Genet       Date:  2004-04-21       Impact factor: 11.025

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.